AI in Oncology Survey
The Research Subcommittee would like to invite members to participate in this MPharm research project. Please find further details below. I am a 4th year pharmacy student at Kingston University…
Read article
Project exploring staff perceptions around the challenges of implementing NICE Technology Appraisal Guidance (TAGs) in Cancer Services
Dear Colleagues, The University of Birmingham and University Hospitals Birmingham are jointly conducting a project exploring staff perceptions around the challenges of implementing NICE Technology Appraisal Guidance (TAGs) in Cancer Services. We…
Pharmacists’ Essential Guide to Haematology Course – 16th and 17th March 2026 at UCLH
Back again by Popular Demand – SAVE THE DATE Pharmacist Essential Guide to Haematology Delivered by UCLH Cancer Academy 16th and 17th March 2026 @ UCLH Education centre Are you…
BOPA Introduction to Cancer Course, Scotland, March 2026 – registration OPENS soon!
The popular Introduction to Cancer Course is coming to to Glasgow in March 2026 The BOPA Introduction to Cancer Course 2026 WHEN: Thursday 26th & Friday 27th March 2026 WHERE: The…
Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement
BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…
BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)
The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…
BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence
With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…
IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events
IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…
Celebrating Success in the BOPA Immunotherapy Group
The BOPA Immunotherapy Cancer Advisory Group, have recently done some research into immune-related cardiac toxicity; both the monitoring for, and management of, these rare but serious adverse effects. Simon Jenkinson,…
Celebrating Black History Month – Celebrating Excellence with Gisela Abbam
In celebration of Black History Month, the Kingston University BAME staff network is excited to invite you to an inspiring session with Gisela Abbam, Chair of the General Pharmaceutical Council (GPhC). Gisela…
Immunotherapy Study Day at Royal Marsden Hospital
The team at the Royal Marsden Hospital are organising an immunotherapy study day on the 3rd December, please see link below for more information. A User Guide to Cancer Immunotherapy…
Collaboration on Reviewing Existing SACT Protocols
Dear BOPA Members, As you may be aware, the National SACT Protocol Project is due to commence shortly in collaboration with the UK SACT Board and the Pharmaceutical Press. The…